...
首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Who will benefit most from hydrogel rectum spacer implantation in prostate cancer radiotherapy? A model-based approach for patient selection
【24h】

Who will benefit most from hydrogel rectum spacer implantation in prostate cancer radiotherapy? A model-based approach for patient selection

机译:谁将受益于来自水凝胶直肠间隔植入前列腺癌放射治疗的大多数人? 一种基于模型的患者选择方法

获取原文
获取原文并翻译 | 示例
           

摘要

Background and purpose: Previous studies confirmed that implantable rectum spacers (IRS) decreased acute gastro-intestinal (GI) toxicity in a significant percentage of prostate cancer patients undergoing intensity modulated radiation therapy (IMRT). We developed decision rules based on clinical risk factors (CRFs) to select those patients who are expected to benefit most from IRS implantation.
机译:背景和目的:以前的研究证实,可植入直肠间隔物(IRS)在接受强度调节的放射治疗(IMRT)的主要百分比的前列腺癌患者中,降低了急性胃肠(GI)毒性。 我们根据临床风险因素(CRF)制定了决策规则,以选择预计从IRS植入中受益的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号